On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development

Statistical Issues and Controversies in Active-Controlled, “Noninferiority” Trials

(2013) Kevin J. Carroll   Statistics in Biopharmaceutical Research

Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study

(2013) H. Naci et al.   BMJ-British Medical Journal

Issues in performing a network meta-analysis

(2012) Stephen Senn et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Statistical approaches for conducting network meta-analysis in drug development

(2011) Byron Jones et al.   PHARMACEUTICAL STATISTICS

The Levels of Evidence and Their Role in Evidence-Based Medicine

(2011) Patricia B. Burns et al.   PLASTIC AND RECONSTRUCTIVE SURGERY

Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2

(2011) David C. Hoaglin et al.   VALUE IN HEALTH

Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1

(2011) Jeroen P. Jansen et al.   VALUE IN HEALTH

PISC Expert Team White Paper: Toward a Consistent Standard of Evidence When Evaluating the Efficacy of an Experimental Treatment From a Randomized, Active-Controlled Trial

(2010) Patrick Peterson et al.   Statistics in Biopharmaceutical Research

A basic introduction to fixed-effect and random-effects models for meta-analysis

(2010) Michael Borenstein et al.   Research Synthesis Methods